The national montelukast survey

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 1, 2005, Pages 47-54

  Barnes, Neil ^a   Thomas, Mike ^b   Price, David ^b   Tate, Helen ^c,d  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c Essex   (United Kingdom)

^d Merck Sharp & Dohme Limited   (United Kingdom)

Author keywords

Montelukast; retrospective; survey

Indexed keywords

MONTELUKAST;

ABDOMINAL PAIN; ADULT; ASTHMA; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPOGLYCEMIA; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL RECORD; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNITED KINGDOM;

EID: 11344261268     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.10.011     Document Type: Article

References (19)

1. 4 and histamine in normal human subjects Thorax 39 1984 500 504
2. 4 and granulocytic infiltration into asthmatic airways Lancet 341 1993 989 990
3. J.M. Drazen, E. Israel, and P.M. O'Byrne Treatment of asthma with drugs modifying the leukotriene pathway N Engl J Med 340 1999 197 206
4. A. Sampson, and S. Holgate Leukotriene modifiers in the treatment of asthma look promising across the board of asthma severity BMJ 316 1998 1257 1258
5. T.F. Reiss, P. Chervinsky, R.J. Dockhorn, S. Shingo, B. Seidenberg, and T.B. Edwards Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma Arch Intern Med 158 1998 1213 1220
6. M. Laviolette, K. Malmstrom, S. Lu, M. Laviolette, K. Malmstrom, and S. Lu Montelukast added to inhaled beclomethasone in treatment of asthma Am J Respir Crit Care Med 160 1999 1862 1868
7. D.B. Price, D. Hernandez, P. Magyar, J. Fiterman, K.M. Beeh, and I.G. James Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma Thorax 58 2003 211 216
8. M.J. Vaquerizo, P. Casan, J. Castillo, M. Perpiña, J. Sanchos, and V. Sobradillo Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma Thorax 58 2003 204 211
9. N. Thomson, and M. Shepherd Leukotriene receptor antagonists as add-on therapy for adults with asthma Thorax 58 2003 190 192 [editorial]
10. M. Thomas, J. Cleland, and D. Price Database studies in asthma pharmacoeconomics: uses, limitations and quality markers Expert Opin Pharmacother 4 2003 351 358
11. M.J. Radford, and J.M. Foody How do observational studies expand the evidence base for therapy? JAMA 286 2001 1228 1230 [editorial]
12. M. Pearson, N. Barnes, M. Thomas, H. Tate, and S. Simnett Evaluating the effectiveness of asthma treatment in real-life practice J Eval Clin Pract 10 2004 297 305
13. H. Milgrom, B. Bender, L. Ackerson, P. Bowery, B. Smith, and C. Rand Noncompliance and treatment failure in children with asthma J Allergy Clin Immunol 98 1996 1051 1057
14. S. Lindgren, B. Bake, and S. Larrson Clinical consequences of inadequate inhalation technique in asthma therapy Eur J Respir Dis 70 1987 93 98
15. B. Williams, G. Noonan, T.F. Reiss, B. Knorr, J. Guerra, and R. White Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older Clin Exp Allergy 31 2001 845 854
16. D.S. Robinson, D. Campbell, and P.J. Barnes Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double blind placebo-controlled trial Lancet 357 2001 2007 2011
17. Prevalence of asthma treated in general practice: lung & asthma information agency fact sheet. Available at: http://www.laia.ac.uk/99_1/99_1. htm. Accessed April 6, 2004.
18. J.F. Maspero, E. Duenas-Meza, B. Volovitz, C. Pinacho Daza, L. Kosa, and F. Vrijens Oral montelukast versus inhaled beclomethasone in 6-11 year old children with asthma: results of an open-label extension study evaluating long term safety, satisfaction, and adherence with therapy Curr Med Res Opin 17 2001 96 104
19. P.J. Helms "Real world" pragmatic clinical trials: what are they and what do they tell us? Pediatr Allergy Immunol 13 2002 4 9